Microfluidics provides rapid measurement of minute quantities of fluid in channels with diameters smaller than human hair. It is part of the bioinformatics technology now essential to post - human genome, drug discovery.
13 November 2001
Fluidigm, of South San Francisco, California, has raised $34m in a private finance round led by Lehman Brothers. New investments came from Euclid SR Partners, US Bancorp Piper Jaffray and GE Capital and follow-ons from existing investors such as Versant Ventures and InterWest Partners.
Said Dr Hingge Hsu, Lehman Brothers MD, “The biochip industry is expected to reach $1 billion with the next few years. Fluidigm’s technology is ideally suited to capitalise on this market because it offers fully integrated, customisable microfluidic chips (for) customers in biotechnology and pharmaceutical(s).”
www.fluidigm.com

Comments
Post new comment